Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate the Long-term (3 Months) Efficacy of L-threo DOPS (DroxiDopa) on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With Multiple System Atrophy (MSA). Comparative Study Versus Placebo

NCT02071459 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT02071459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02071459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate the Long-term (3 Months) Efficacy of L-threo DOPS (DroxiDopa) on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With Multiple System Atrophy (MSA). Comparative Study Versus Placebo
Lead sponsor
University Hospital, Toulouse
Phase
Phase 2/3
Overall status
Completed
Start date
January 21, 2014
Completion date
October 28, 2019
Enrollment
107 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

multiple system atrophy